ArticleCancer diagnosis & prognosis

Factors Influencing Severe Hematologic Toxicity Following Niraparib Therapy in Patients With Ovarian Cancer.

Michio Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.